Cardiol Therapeutics Inc. (CRDL) Fundamentals

Cardiol Therapeutics' lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is currently being evaluated in a Phase II/III multi-national study, the LANCER trial. Cardiol has also received IND authorization from the FDA to conduct clinical studies to evaluate CardiolRx in two orphan drug indications: (i) a Phase II multi-national trial in acute myocarditis; and (ii) a Phase II multicenter open-label pilot study in recurrent pericarditis.
SHARE INFORMATION
Market Cap$ 84,222,079
Shares Outstanding61,939,999
Float61,927,999
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 61,129
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions53
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months993,031
Institutional Holdings Percent19.8%
Institutional Sold Previous 3 Months405,237
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 4.96
52 Week Low$ 1.00
52 Week High Change$ -43.57
21 Day Moving Average$ 1.4136
21 Day Extended Moving Average$ 1.4005
50 Day Moving Average$ 1.3633
50 Day Extended Moving Average$ 1.4057
200 Day Moving Average$ 2.1032
200 Day Extended Moving Average$ 1.8672
10 Day Average Volume104,578
20 Day Average Volume174,100
30 Day Average Volume172,928
50 Day Average Volume221,675
Alpha-0.023447
Beta1.1239
Standard Deviation0.204450
R20.079598
7 Day Price Change$ 0.03
7 Day Percent Change2.26%
21 Day Price Change$ -0.20
21 Day Percent Change-12.82%
30 Day Price Change$ 0.09
30 Day Percent Change7.09%
Month to Date Price Change$ 0.02
Month to Date Percent Change1.49%
Quarter to Date Price Change$ -0.17
Quarter to Date Percent Change-11.11%
180 Day Price Change$ -0.50
180 Day Percent Change-26.88%
200 Day Price Change$ -0.75
200 Day Percent Change-35.55%
Year to Date Price Change$ -0.49
Year to Date Percent Change-26.49%

Cardiol Therapeutics Inc. (CRDL) Key Ratios

PROFITABILITY
EBIT Margin-50,118.2%
EBITDA Margin-49,839.6%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 61,129
Revenue Per Share$ 0.001
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.70
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio7.80
Leverage Ratio1.10
Quick Ratio7.40
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-3.10
Enterprise Value$ 31,972,049
Price to Sales1,378.0431
Price to Free Cash-4.60
PE High Last 5 Years0.00
Price To Book1.70
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.20
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-63.84
Return on Equity-73.38
Return on Capital-72.61

Cardiol Therapeutics Inc. (CRDL) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorBDO Canada LLP
CEODavid G. Elsley
Emplyoees11
Last AuditUQ
CIK0001702123
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2265 Upper Middle Road East
Suite 602
Oakville, ON L6H 0G5
Websitehttps://www.cardiolrx.com
Facsimile-
Telephone+1 289 910-0850
Emailtrevor.burns@cardiolrx.com
Your Recent History
NASDAQ
CRDL
Cardiol Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220701 01:18:13